IU researcher seeks to solve “black box” nature of AI, presents groundbreaking research at Spring ADRC
2025 REC Scholar Selena Wang, PhD, is trying find the answer to many complexities of the brain and Alzheimer’s disease using Artificial Intelligence. Advancements in Artificial Intelligence are providing new promise to the biomedical research community, and yet the often “black box” nature of modern-day AI tools leads to trust issues.
Nation's largest early-onset Alzheimer's study drives diversity
LEADS, led by Liana Apostolova, MD, has received $78 million in National Institute of Aging (NIA) funding since it launched in 2018. It's also the
Reprogramming cell in adult central nervous system promotes regeneration of motor function axons after spinal cord injury
Led by Wei Wu, PhD, assistant professor of neurological surgery and a primary member of Stark Neurosciences Research Institute, the researchers discovered a connection between the reprogramming of NG2
Top 10 largest NIH grants funding research in 2023
Grants funding Alzheimer's disease, global health and opioid addiction research were among the largest NIH awards to the IU School of Medicine during federal fiscal
Neuroscientists receive NIH grants to investigate brain’s role in addiction, anxiety and obesity
Three Indiana University School of Medicine researchers each received National Institutes of Health grant funding to study under-explored mechanisms and connections in the brain using
Glaucoma research program growing at IU School of Medicine
Glick Eye Institute researchers Arupratan Das, PhD, Padmanabhan Pattabiraman, PhD, Weiming Mao, PhD and Tasneem Sharma, PhD—also members of the ocular neurobiology research interest group
Neurologists at IU administer first-of-its-kind FDA-approved gene therapy
Neurologists at Indiana University School of Medicine are among the first clinicians in the nation to administer a groundbreaking gene-based therapy for patients living with
IU administering, leading clinical research on FDA-approved Alzheimer’s drug
For nearly a decade, lecanemab has been tested in clinical trials at IU School of Medicine—the newly FDA-approved drug is now being administered to patient
A new era for radiology at IU
A new era began for the Department of Radiology and Imaging Sciences at Indiana University School of Medicine this fall with the arrival of new
Neurology postdoctoral scholar awarded first Alzheimer's Association Perelman Fellowship
The Alzheimer’s Association recently named Kate Foley, PhD, postdoctoral fellow in the Department of Neurology at Indiana University School of Medicine, as the inaugural Dr.